Advertisement
ENOV vs PHG
Which Stock Would AI Choose? Enovis Corporation (ENOV) vs. Koninklijke Philips N.V. (PHG) Stock Comparison
Key Takeaways
- Enovis Corporation (ENOV) has shown a strong rebound in recent weeks, with shares up approximately 15% over the past month and positive year-to-date gains of 11.34%.
- Koninklijke Philips N.V. (PHG) has experienced recent weakness, down about 4% over the past month and 3.4% year-to-date, amid broader market pressures.
- ENOV, a medical devices firm, carries higher volatility (beta of 1.59) compared to PHG's more stable profile (beta around 0.8-1.0), appealing to growth-oriented traders.
- Analysts rate ENOV as Outperform with a $44.73 target, implying significant upside, while PHG offers a steady dividend yield.
- Both operate in the healthcare sector, but ENOV focuses on orthopedics with higher growth potential, versus PHG's diversified health technology portfolio.
Introduction
Enovis Corporation (ENOV) and Koninklijke Philips N.V. (PHG) represent key players in the healthcare equipment and medical devices sector, making them compelling for comparison amid evolving medtech demands. Investors and traders eyeing sector exposure—whether for growth momentum or defensive stability—can benefit from analyzing their relative performance. Recent market activity highlights contrasts in momentum and risk, influenced by earnings anticipation, analyst views, and macroeconomic factors. This stock comparison evaluates business contexts, price behaviors, and sentiment shifts to inform strategic positioning in the current environment.
ENOV Overview and Recent Performance
Enovis Corporation (ENOV) is a healthcare company specializing in orthopedic medical devices, including reconstructive implants and enabling technologies. Trading at around $23.62 with a market cap of $1.36 billion, it operates in the medical devices industry. In recent market activity, ENOV has exhibited resilient momentum, rebounding sharply with gains of about 15% over the past 30 days and 8% in the prior 12 weeks, alongside year-to-date returns of 11.34%. This uptrend reflects positive sentiment from analyst upgrades, such as William Blair's Outperform rating, and anticipation for upcoming earnings on May 7, 2026. Higher beta (1.59, a measure of stock volatility relative to the market) underscores its sensitivity to sector news, driving trader interest despite negative trailing EPS.
PHG Overview and Recent Performance
Koninklijke Philips N.V. (PHG), a global leader in health technology, provides diagnostic imaging, patient monitoring, and connected care solutions. With shares near $26.50 and a substantial market cap exceeding $22 billion, it spans the healthcare equipment sector. Recent weeks have seen softer performance for PHG, with declines of roughly 4% over the past month, 9.5% in three months, and 3.4% year-to-date, amid dividend announcements and profitability improvements reported for 2025. Factors influencing sentiment include a recent dividend of $1.013 (ex-date May 13, 2026) and ongoing portfolio adjustments, though shares remain range-bound within a 52-week span of $21.95 to $33.44. Lower beta (around 0.8-1.0) signals relative stability, attracting income-focused investors despite short-term pullbacks.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases 25 top-performing AI trading bots curated from over 351 available models that trade thousands of tickers across stocks, ETFs, and crypto. These bots, selected by AI analysis for current market conditions, deliver impressive stats: annualized returns ranging from 23.53% to 163.10%, win rates of 51.30% to 88.33%, and profit factors up to 11.70. Trading styles vary from trend and swing to volatility-focused strategies with timeframes like 1D to 49D and multi-ticker portfolios in sectors such as semiconductors, space, and finance. Neither ENOV nor PHG features prominently, but the page emphasizes risk-managed copy trading signals outperforming benchmarks like the S&P 500. Explore these bots to align automated strategies with your portfolio.
Head-to-Head Comparison
Enovis (ENOV) pursues a focused business model in orthopedic devices, emphasizing innovation in reconstructive surgery, while Philips (PHG) offers diversified healthtech across imaging and monitoring, providing broader revenue streams but slower growth. Recent momentum favors ENOV with its rebound versus PHG's declines, reflecting small-cap agility against large-cap steadiness. Risk profiles diverge: ENOV's higher beta exposes it to volatility, contrasting PHG's defensive beta and dividend appeal. Both share healthcare sector exposure, but ENOV shows stronger analyst upside potential amid catalysts like earnings, while PHG trades at a premium valuation with stability trade-offs.
Tickeron AI Verdict
Tickeron’s AI models currently lean toward ENOV over PHG, driven by superior recent trend consistency, positive year-to-date performance, and substantial analyst-implied upside from current levels. ENOV's momentum and sector catalysts position it favorably for short-term relative strength, though PHG may appeal in risk-averse scenarios. This assessment reflects observable market data rather than guarantees.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENOV is a Hold and PHG is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ENOV’s FA Score shows that 0 FA rating(s) are green whilePHG’s FA Score has 1 green FA rating(s).
- ENOV’s FA Score: 0 green, 5 red.
- PHG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ENOV’s TA Score shows that 6 TA indicator(s) are bullish while PHG’s TA Score has 5 bullish TA indicator(s).
- ENOV’s TA Score: 6 bullish, 4 bearish.
- PHG’s TA Score: 5 bullish, 4 bearish.
Price Growth
ENOV (@Medical/Nursing Services) experienced а +7.75% price change this week, while PHG (@Medical/Nursing Services) price change was +2.12% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.80%. For the same industry, the average monthly price growth was -1.65%, and the average quarterly price growth was -4.18%.
Reported Earning Dates
ENOV is expected to report earnings on Jul 30, 2026.
PHG is expected to report earnings on Jul 28, 2026.
Industries' Descriptions
@Medical/Nursing Services (-0.80% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ENOV | PHG | ENOV / PHG | |
| Capitalization | 1.5B | 25.7B | 6% |
| EBITDA | -770.33M | 2.68B | -29% |
| Gain YTD | -2.440 | -0.258 | 944% |
| P/E Ratio | N/A | 22.95 | - |
| Revenue | 2.28B | 17.6B | 13% |
| Total Cash | 33.1M | 2.59B | 1% |
| Total Debt | 1.41B | 8.1B | 17% |
ENOV | PHG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 16 | 8 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 5 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 98 | 76 | |
PRICE GROWTH RATING 1..100 | 60 | 62 | |
P/E GROWTH RATING 1..100 | 98 | 99 | |
SEASONALITY SCORE 1..100 | 50 | 28 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PHG's Valuation (5) in the Electronic Production Equipment industry is significantly better than the same rating for ENOV (77) in the Industrial Machinery industry. This means that PHG’s stock grew significantly faster than ENOV’s over the last 12 months.
PHG's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ENOV (100) in the Industrial Machinery industry. This means that PHG’s stock grew similarly to ENOV’s over the last 12 months.
PHG's SMR Rating (76) in the Electronic Production Equipment industry is in the same range as ENOV (98) in the Industrial Machinery industry. This means that PHG’s stock grew similarly to ENOV’s over the last 12 months.
ENOV's Price Growth Rating (60) in the Industrial Machinery industry is in the same range as PHG (62) in the Electronic Production Equipment industry. This means that ENOV’s stock grew similarly to PHG’s over the last 12 months.
ENOV's P/E Growth Rating (98) in the Industrial Machinery industry is in the same range as PHG (99) in the Electronic Production Equipment industry. This means that ENOV’s stock grew similarly to PHG’s over the last 12 months.
| ENOV | PHG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 72% | 1 day ago 77% |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 65% |
| Momentum ODDS (%) | 1 day ago 65% | 1 day ago 57% |
| MACD ODDS (%) | 1 day ago 70% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 64% | 1 day ago 59% |
| TrendMonth ODDS (%) | 1 day ago 60% | 1 day ago 60% |
| Advances ODDS (%) | 7 days ago 61% | 8 days ago 62% |
| Declines ODDS (%) | 3 days ago 77% | 15 days ago 64% |
| BollingerBands ODDS (%) | 1 day ago 76% | 1 day ago 74% |
| Aroon ODDS (%) | 1 day ago 48% | 1 day ago 61% |
Advertisement
ENOV and
Correlation & Price change
A.I.dvisor indicates that over the last year, ENOV has been loosely correlated with CNMD. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ENOV jumps, then CNMD could also see price increases.
| Ticker / NAME | Correlation To ENOV | 1D Price Change % | ||
|---|---|---|---|---|
| ENOV | 100% | +4.88% | ||
| CNMD - ENOV | 59% Loosely correlated | +2.10% | ||
| FELE - ENOV | 56% Loosely correlated | -1.19% | ||
| DOV - ENOV | 55% Loosely correlated | -1.48% | ||
| IART - ENOV | 54% Loosely correlated | -1.43% | ||
| PH - ENOV | 53% Loosely correlated | +0.80% | ||
More | ||||
PHG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PHG has been loosely correlated with RYLPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if PHG jumps, then RYLPF could also see price increases.
| Ticker / NAME | Correlation To PHG | 1D Price Change % | ||
|---|---|---|---|---|
| PHG | 100% | +1.05% | ||
| RYLPF - PHG | 56% Loosely correlated | N/A | ||
| GEHC - PHG | 52% Loosely correlated | +0.96% | ||
| ALC - PHG | 49% Loosely correlated | +2.84% | ||
| CNMD - PHG | 46% Loosely correlated | +2.10% | ||
| ENOV - PHG | 43% Loosely correlated | +4.88% | ||
More | ||||